Patents by Inventor Michal Amit

Michal Amit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7592175
    Abstract: The present invention is of methods of establishing and propagating human embryonic stem cell lines using feeder cells-free, xeno-free culture systems and stem cells which are capable of being maintained in an undifferentiated, pluripotent and proliferative state in culture which is free of xeno contaminants and feeder cells.
    Type: Grant
    Filed: December 7, 2003
    Date of Patent: September 22, 2009
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Publication number: 20090196860
    Abstract: An isolated primate embryonic cell is provided as well as cell cultures and cell lines derived therefrom. Also provided are methods of generating and using such cells.
    Type: Application
    Filed: October 11, 2005
    Publication date: August 6, 2009
    Applicant: TECHNION RESEARCH & DSEVELOPMENT
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Publication number: 20070269790
    Abstract: Stem cells, stem cell lines and differentiated cells, tissues and organs which carry disease-causing mutations are provided. There is also provided a method of identifying agents suitable for treating disorders associated with at least one disease-causing mutations such as myotonic dystrophy and van Waardenburg syndrome.
    Type: Application
    Filed: June 1, 2006
    Publication date: November 22, 2007
    Applicant: TECHNION RESEARCH & DEVELOPMENT
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Publication number: 20070259426
    Abstract: A cell culture comprising human foreskin cells, the human foreskin cells being capable of maintaining stem cells in an undifferentiated state when co-cultured therewith.
    Type: Application
    Filed: July 6, 2007
    Publication date: November 8, 2007
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Patent number: 7267981
    Abstract: A cell culture comprising human foreskin cells, the human foreskin cells being capable of maintaining stem cells in an undifferentiated state when co-cultured therewith.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: September 11, 2007
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Publication number: 20060051862
    Abstract: The present invention is of methods of establishing and propagating human embryonic stem cell lines using feeder cells-free, xeno-free culture systems and stem cells which are capable of being maintained in an undifferentiated, pluripotent and proliferative state in culture which is free of xeno contaminants and feeder cells.
    Type: Application
    Filed: December 7, 2003
    Publication date: March 9, 2006
    Applicant: Technion Research & Development Foundation
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Publication number: 20050037489
    Abstract: A method of generating cells predominantly displaying at least one characteristic associated with a cardiac phenotype is disclosed. The method comprises (a) partially dispersing a confluent cultured population of human stem cells, thereby generating a cell population including cell aggregates; (b) subjecting said cell aggregates to culturing conditions suitable for generating embryoid bodies; (c) subjecting said embryoid bodies to culturing conditions suitable for inducing cardiac lineage differentiation in at least a portion of the cells of said embryoid bodies, said culturing conditions suitable for inducing cardiac lineage differentiation including adherence of said embryoid bodies to a surface, and culture, medium supplemented with serum, thereby generating cells predominantly displaying at least one characteristic associated with a cardiac phenotype.
    Type: Application
    Filed: January 20, 2004
    Publication date: February 17, 2005
    Inventors: Lior Gepstein, Izhak Kehat, Joseph Itskovitz-Eldor, Michal Amit
  • Publication number: 20040191901
    Abstract: The present invention discloses insulin producing cells derived from human embryonic stem cells. Methods of generating, enriching, selecting, cloning and isolating populations of insulin-producing embryonic cell lines are disclosed. Insulin production in these cells can be glucose responsive or otherwise regulatable. Advantageously, these insulin producing cells can be stable cell lines derived from stable transfectants of hESC. Methods of using these cells, cell populations or cell lines particularly for cell replacement therapy are also disclosed.
    Type: Application
    Filed: November 14, 2003
    Publication date: September 30, 2004
    Inventors: Suheir Assady, Gila Maor, Michal Amit, Joseph Itskovitz-Eldor, Karl L. Skorecki, Maty Tzukerman
  • Publication number: 20040067580
    Abstract: A cell culture comprising human foreskin cells, the human foreskin cells being capable of maintaining stem cells in an undifferentiated state when co-cultured therewith.
    Type: Application
    Filed: February 19, 2003
    Publication date: April 8, 2004
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Publication number: 20040009589
    Abstract: The invention is a population of embryonic endothelial cells produced in vitro from human embryonic stem cells. The cells produce platelet endothelial cell adhesion molecule-1 and are vasculogenic. The cells may be combined with a cell support substrate, seeded on a polymer matrix, or combined with a cell-support substrate that is infused into a polymer matrix. The cells may also be injected directly into a tissue site.
    Type: Application
    Filed: March 25, 2003
    Publication date: January 15, 2004
    Inventors: Shulamit Levenberg, Michal Amit, Joseph Itskovitz-Eldor, Robert Langer
  • Publication number: 20030073234
    Abstract: A method of establishing a clonal embryonic stem cell line capable of sustaining a phenotype of normal embryonic stem cells following at least eight months of in vitro culture is disclosed. The method is effected by culturing an individual embryonic stem cell for at least eight months in a serum-free medium, thereby establishing the clonal embryonic stem cell line capable of sustaining said phenotype of normal embryonic stem cells following at least eight months of in vitro culture.
    Type: Application
    Filed: October 12, 2001
    Publication date: April 17, 2003
    Inventors: Michal Amit, James A. Thomson